Ann: Successful $1.65m Placement/International Expansion, page-23

Re-Rate in Progress. Honestly speaking, IHL was a dental company and only recently forayed into the MedCann business. To play Devil's Advocate, whilst our potential and current MC is unbelievable compared to our peers, we still have not actually done anything in this space yet.
I believe in the company and from here to 2020 will be where it all happens or it just doesn't.

What we have lined up is more than enough to warrant the company being rated similarly or higher than our peers when the successful results come out. Until then, I am happy with positive sentiment and currently it is being soaked.

Because when it rains, it pours and this will be nothing to when we get our results back for our PHASE 2 TRIAL. But wait there's more, make it FOUR.

IMO, the CR has happened, wait for the 3B to come through, strong support at 4.0 and floor at 3.8. With the IHLOBs expiring in Sep 2020, and the CannVaLate options expiring between Jan 2020 to Dec 2020, if those are all exercised Impression will be cashed up to the roof.
Of course, as the year goes on and we sell the oils from AXIM, through CannVaLate and our trials kick off, Shenzen manufacturing move to save 800K, moving into the US for more sales, all you need is patience.

DYOR, No reason to complain over our current MC versus others when we are in early stages. When we have our trials, it will all be justified and we will fly.